结直肠癌
转移
医学
免疫疗法
癌症
干扰素
免疫系统
癌症研究
肿瘤微环境
免疫学
肝癌
肿瘤科
癌细胞
内科学
作者
Bernadette Mödl,Stefan Moritsch,Daniela Zwolanek,Robert Eferl
出处
期刊:Cytokine
[Elsevier BV]
日期:2022-10-30
卷期号:161: 156075-156075
被引量:5
标识
DOI:10.1016/j.cyto.2022.156075
摘要
Metastatic colorectal cancer is one of the leading causes of cancer-related deaths worldwide. Traditional chemotherapy extended the lifespan of cancer patients by only a few months, but targeted therapies and immunotherapy prolonged survival and led to long-term remissions in some cases. Type I and II interferons have direct pro-apoptotic and anti-proliferative effects on cancer cells and stimulate anti-cancer immunity. As a result, interferon production by cells in the tumor microenvironment is in the spotlight of immunotherapies as it affects the responses of anti-cancer immune cells. However, promoting effects of interferons on colorectal cancer metastasis have also been reported. Here we summarize our knowledge about pro- and anti-metastatic effects of type I and II interferons in colorectal cancer liver metastasis and discuss possible therapeutic implications.
科研通智能强力驱动
Strongly Powered by AbleSci AI